Alterations in intestinal Proteobacteria and antimicrobial resistance gene burden in individuals administered microbial ecosystem therapeutic (MET-2) for recurrent<i>Clostridioides difficile</i>infection
bioRxiv (Cold Spring Harbor Laboratory)